Diana G. Glovaci

Diana Glovaci practices at Los Alamitos Cardiovascular in Los Alamitos, California.

Diana Glovaci's NPI, 1366805590, was assigned on April 4, 2016. Diana Glovaci graduated from Touro College of Osteopathic Medicine - New York in 2016. Diana Glovaci's California license number on file is 20A15851.

Diana Glovaci's primary practice is Los Alamitos Cardiovascular, at 5300 Katella Ave, Los Alamitos, CA 90720-2808. The practice phone is (562) 430-7533.

Diana Glovaci's primary practice is Los Alamitos Cardiovascular in Los Alamitos, California. Diana Glovaci is also affiliated with UCI Health - Orange. The medical group on file is Los Alamitos Cardiovascular. Dmand AI also links Diana Glovaci to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Diana Glovaci practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Diana Glovaci's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Diana Glovaci is board certified in cardiovascular disease by the American Board of Internal Medicine. Diana Glovaci has a license on file in California.

Dmand AI lists acute mini-stroke (TIA), asthma, atrial fibrillation and flutter, cerebrovascular disease, chronic diabetes, chronic hypertension, coronary artery disease and epilepsy among the conditions Diana Glovaci treats.

CMS data shows 1,977 Medicare services from Diana Glovaci across 22 procedure codes in 2024, for 861 Medicare patients. Medicare paid $156,535 for them.

CMS counts 861 Medicare patients who saw Diana Glovaci in 2024. The largest group is 75 to 84, with 314 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Diana Glovaci's median patient age at 66, with 54% women.

In 2024, Diana Glovaci wrote 1,845 Medicare Part D claims for 325 patients. 75% of them were for generic drugs. CMS names the drug for 1,687 of them, across 28 drugs with 11 or more claims each, at $443,277 in total drug cost. In 2023, CMS named 1,294 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Diana Glovaci for performance year 2024, reported individually. Diana Glovaci accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Diana Glovaci, published from 2011 to 2022. 2012 was the busiest year, with 4. The most frequent topics are Cardiovascular Diseases, Comorbidity and Diabetes Mellitus, Type 2. Diana Glovaci has published most often in Future Cardiol. Diana Glovaci's most frequent co-authors are Pranav M. Patel, MD, Uchenna H. Iloeje, MD and Shaista Malik, MD.

CMS Open Payments shows 136 general payments to Diana Glovaci from 26 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 95% of the total. Boston Scientific Corporation paid the most, $487.

Diana Glovaci graduated from Touro College of Osteopathic Medicine - New York in 2016.

Diana Glovaci is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.